YOUR PRECLINICAL CRO FOR CARDIOVASCULAR ASSAYS
GLP-certified expertise at your service
PhysioStim is a preclinical Contract Research Organization that specializes in cardiovascular pharmacology and electrophysiology studies for preclinical drug development purposes. We’re recognized as one of Europe’s most reliable CROs when it comes to cardiac safety. Our experts offer electrophysiological studies and preclinical resources as well as their dedicated expertise in answering ICH S7A and S7B guidelines in accordance with GLP (Good Laboratory Practices). We also respect the 3R principle and have already taken steps to comply with the upcoming CIPA guidelines.
We help pharmaceutical & biotech companies
Study the cardiovascular safety of a given compound
Derisk compounds at an early stage
Select the right Lead Candidate(s) during the preclinical stage
Determine early evaluation of compounds able to induce QT prolongation
Your expert in cardiac safety assays
MANDATORY PRECLINICAL STUDIES
GLP-certified preclinical ICH S7B & S7A-compliant assays
FOLLOW-UP STUDIES TO COMPLETE YOUR DATA
A wide range of in vitro and in vivo assays for cardiac safety studies
The right study model to guarantee excellence
A wide selection for reliable preclinical safety studies
The experts at PhysioStim go beyond standard study guidelines to conduct their safety studies. We provide a wide range of possibilities to conduct both mandatory and complementary studies and help your project move forward. PhysioStim has over 17 years of expertise in developing in vitro and ex vivo models to investigate potential drug-related cardiac adverse effects. We provide cellular models as well as tissue and organ models.